Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells-Reference-Cited by-同舟云学术

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1475-2867
Container-title:Cancer Cell International
language:en
Short-container-title:Cancer Cell Int

Author:

Petővári Gábor,Hujber Zoltán,Krencz Ildikó,Dankó Titanilla,Nagy Noémi,Tóth Fanni,Raffay Regina,Mészáros Katalin,Rajnai Hajnalka,Vetlényi Enikő,Takács-Vellai Krisztina,Jeney András,Sebestyén Anna

Funder

Scientific and Innovative Research Found of Semmelweis University

Bolyai Fellowship Program of the Hungarian Academy of Sciences

Hungarian National Talent and National Excellence Programs

Richter Centenarium Foundation Fellowship

Hungarian National Research

Emberi Eroforrások Minisztériuma

Development and Innovation Office

National Bionics Program of Hungary

National Research, Development and Innovation Office

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12935-018-0710-0.pdf

Reference44 articles.

1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20. https://doi.org/10.1007/s00401-016-1545-1 .

2. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O’Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, TCGA Research Network. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462–77. https://doi.org/10.1016/j.cell.2013.09.034 .

3. Babak S, Mason WP. mTOR inhibition in glioblastoma: requiem for a dream? Neuro Oncol. 2018;20(5):584–5. https://doi.org/10.1093/neuonc/noy034 .

4. Winkler F, Osswald M, Wick W. Anti-angiogenics: their role in the treatment of glioblastoma. Oncol Res Treat. 2018;41(4):181–6. https://doi.org/10.1159/000488258 .

5. Lin F, de Gooijer MC, Hanekamp D, Chandrasekaran G, Buil LC, Thota N, Sparidans RW, Beijnen JH, Würdinger T, van Tellingen O. PI3K-mTOR pathway inhibition exhibits efficacy against high-grade glioma in clinically relevant mouse models. Clin Cancer Res. 2017;23(5):1286–98. https://doi.org/10.1158/1078-0432.CCR-16-1276 .

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies;Pathology and Oncology Research;2024-03-07

2. PI3K Signaling Pathways as a Molecular Target for Glioblastoma Multiforme;Current Protein & Peptide Science;2024-01

3. Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing;Scientific Reports;2023-11-10

4. Dissecting the Role of Autophagy-Related Proteins in Cancer Metabolism and Plasticity;Cells;2023-10-19

5. NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism;Communications Biology;2023-06-02